title: Reply to: Assessing physico-chemical compatibility of concomitantly diluted antiemetics including palonosetron-HCl and fosaprepitant dimeglumine.
authors.affiliation: Merck and Co, Inc., Whitehouse Station, NJ, USA, brett_duersch@merck.com.
authors.forename: Brett
authors.initials: B
authors.lastname: Duersch
mesh_terms: D000932:Antiemetics / Q000737:chemistry*; D005938:Glucocorticoids / Q000737:chemistry*; D009025:Morpholines / Q000737:chemistry*; D058831:Serotonin 5-HT3 Receptor Antagonists / Q000737:chemistry*
chemical_list: D000932:Antiemetics; D005938:Glucocorticoids; D009025:Morpholines; D058831:Serotonin 5-HT3 Receptor Antagonists